Literature DB >> 4809201

Effect of clofibrate on plasma glucose and serum immunoreactive insulin in patients with hyperlipoproteinemia.

R W Fenderson, I Sekowski, C Mohan, S Deutsch, F Benjamin, P Samuel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4809201     DOI: 10.1093/ajcn/27.1.22

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


× No keyword cloud information.
  7 in total

1.  Effect of clofibrate on glucose tolerance in maturity onset diabetes.

Authors:  D Barnett; J G Craig; D S Robinson; M P Rogers
Journal:  Br J Clin Pharmacol       Date:  1977-08       Impact factor: 4.335

2.  Effects of clofibrate on glucose tolerance, serum insulin, serum lipoproteins and plasma fibrinogen.

Authors:  H Lithell; J Boberg; H Hedstrand; K Hellsing; S Ljunghall; B Vessby
Journal:  Eur J Clin Pharmacol       Date:  1977-08-17       Impact factor: 2.953

3.  Inhibitory effect of clofibrate on arginine-induced insulin secretion in chemical diabetes.

Authors:  A E Pontiroli; G Viberti; G Pozza
Journal:  Acta Diabetol Lat       Date:  1976 May-Aug

4.  Clofibrate and diabetes control in patients treated with oral hypoglycaemic agents.

Authors:  J C Daubresse; D Daigneux; M Bruwier; A Luyckx; P J Lefebvre
Journal:  Br J Clin Pharmacol       Date:  1979-06       Impact factor: 4.335

5.  Clofibrate in insulin-dependent diabetes.

Authors:  C Twomey; A Bloom
Journal:  Ir J Med Sci       Date:  1979-12       Impact factor: 1.568

6.  Modification of intracellular glucose metabolism in human skin fibroblast preincubated with p-chlorophenoxyisobutyrate.

Authors:  T Nishide; K Shirai; Y Saito; S Yoshida
Journal:  Br J Clin Pharmacol       Date:  1987-12       Impact factor: 4.335

Review 7.  Changes in Plasma Free Fatty Acids Associated with Type-2 Diabetes.

Authors:  Amélie I S Sobczak; Claudia A Blindauer; Alan J Stewart
Journal:  Nutrients       Date:  2019-08-28       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.